Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (... von Reck, M., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V., Hirsh, V., Leighl, N., Mezger, J., Archer, V., Moore, N., Manegold, C.

Volltext

Bone matters in lung cancer von Brodowicz, T., O'Byrne, K., Manegold, C.

Volltext

ROS1 fusions in Chinese patients with non-small-cell lung cancer von Cai, W., Li, X., Su, C., Fan, L., Zheng, L., Fei, K., Zhou, C., Manegold, C., Schmid-Bindert, G.

Volltext

Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency von Brun, L, Ngu, L H, Keng, W T, Ch'ng, G S, Choy, Y S, Hwu, W L, Lee, W T, Willemsen, M A A P, Verbeek, M M, Wassenberg, T, Régal, L, Orcesi, S, Tonduti, D, Accorsi, P, Testard, H, Abdenur, J E, Tay, S, Allen, G F, Heales, S, Kern, I, Kato, M, Burlina, A, Manegold, C, Hoffmann, G F, Blau, N

Volltext

Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? von Schmid-Bindert, G., Henzler, Thomas, Chu, T. Q., Meyer, M., Nance, J. W., Schoepf, U. J., Dinter, D. J., Apfaltrer, P., Krissak, R., Manegold, C., Schoenberg, S. O., Fink, C.

Volltext

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant... von Novello, S., Torri, V., Grohe, C., Kurz, S., Serke, M., Wehler, T., Meyer, A., Ladage, D., Geissler, M., Colantonio, I., Cauchi, C., Stoelben, E., Ceribelli, A., Kropf-Sanchen, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Gregorc, V., Chiari, R., Reck, M., Schmid-Bindert, G., Folprecht, G., Griesinger, F., Follador, A., Pedrazzoli, P., Bearz, A., Caffo, O., Dickgreber, N.J., Irtelli, L., Wiest, G., Monica, V., Porcu, L., Manegold, C., Scagliotti, G.V.

Volltext

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors o... von Efficace, F, Bottomley, A, Smit, EF, Lianes, P, Legrand, C, Debruyne, C, Schramel, F, Smit, HJ, Gaafar, R, Biesma, B, Manegold, C, Coens, C, Giaccone, G, Van Meerbeeck, J

Volltext

Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up von Manegold, C

Volltext

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer von Manegold, C., van Zandwijk, N., Szczesna, A., Zatloukal, P., Au, J.S.K., Blasinska-Morawiec, M., Serwatowski, P., Krzakowski, M., Jassem, J., Tan, E.H., Benner, R.J., Ingrosso, A., Meech, S.J., Readett, D., Thatcher, N.

Volltext

Antiangiogenic Therapy with Mammalian Target of Rapamycin Inhibitor RAD001 (Everolimus) Increases Radiosensitivity in Solid Cancer von MANEGOLD, Philipp C, PARINGER, Carmen, KULKA, Ulrike, KRIMMEL, Klaus, EICHHORN, Martin E, WILKOWSKI, Ralf, JAUCH, Karl-Walter, GUBA, Markus, BRUNS, Christiane J

Volltext

Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus s... von Novello, S., Torri, V., Grohe, C., Kurz, S., Serke, M., Wehler, T., Meyer, A., Ladage, D., Geissler, M., Colantonio, I., Cauchi, C., Stoelben, E., Ceribelli, A., Kropf-Sanchen, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Gregorc, V., Chiari, R., Reck, M., Schmid-Bindert, G., Folprecht, G., Griesinger, F., Follador, A., Pedrazzoli, P., Bearz, A., Caffo, O., Dickgreber, N.J., Irtelli, L., Wiest, G., Monica, V., Porcu, L., Manegold, C., Scagliotti, G.V.

Volltext

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma von Manegold, C., Symanowski, J., Gatzemeier, U., Reck, M., von Pawel, J., Kortsik, C., Nackaerts, K., Lianes, P., Vogelzang, N. J.

Volltext

Sunitinib in metastatic thymic carcinomas: Laboratory findings and initial clinical experience von Ströbel, P, Bargou, R, Wolff, A, Spitzer, D, Manegold, C, Dimitrakopoulou-Strauss, A, Strauss, L, Sauer, C, Mayer, F, Hohenberger, P, Marx, A

Volltext

Aromatic l-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up von Manegold, C, Hoffmann, G. F, Degen, I, Ikonomidou, H, Knust, A, Laaß, M. W, Pritsch, M, Wilichowski, E, Hörster, F

Volltext

Thymidylate synthase gene variations: predictive and prognostic markers von Lurje, Georg, Manegold, Philipp C, Ning, Yan, Pohl, Alexandra, Zhang, Wu, Lenz, Heinz-Josef

Volltext

Malignant peritoneal mesothelioma—Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent von Carteni, G, Manegold, C, Garcia, G. Martin, Siena, S, Zielinski, C.C, Amadori, D, Liu, Y, Blatter, J, Visseren-Grul, C, Stahel, R

Volltext

Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trial von Lesaffre, E., Edelman, M.J., Hanna, N.H., Park, K., Thatcher, N., Willemsen, S., Gaschler-Markefski, B., Kaiser, R., Manegold, C.

Volltext

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer von Syrigos, K.N., Vansteenkiste, J., Parikh, P., von Pawel, J., Manegold, C., Martins, R.G., Simms, L., Sugarman, K.P., Visseren-Grul, C., Scagliotti, G.V.

Volltext

MS 14.01 Elements to Reach the Treatment Goal of Palliation von Manegold, C.

Volltext

Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules von Körner, A, Mudduluru, G, Manegold, C, Allgayer, H

Volltext